SURPASS EVOLVE
Device
Stryker Corporation
Total Payments
$8.0M
Transactions
7,889
Doctors
1,071
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.8M | 1,854 | 428 |
| 2023 | $1.9M | 1,726 | 372 |
| 2022 | $2.1M | 2,034 | 467 |
| 2021 | $2.2M | 2,275 | 446 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4.0M | 1,239 | 50.2% |
| Unspecified | $3.2M | 444 | 40.1% |
| Travel and Lodging | $331,560 | 1,116 | 4.1% |
| Food and Beverage | $245,594 | 5,038 | 3.1% |
| Space rental or facility fees (teaching hospital only) | $190,529 | 49 | 2.4% |
| Grant | $6,500 | 2 | 0.1% |
| Education | $21.62 | 1 | 0.0% |
Payments by Type
General
$4.8M
7,445 transactions
Research
$3.2M
444 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| EVOLVE | Stryker Corporation | $2.5M | 1 |
| THE SURPASS INTRACRANIAL ANEURYSM EMBOLIZATION SYSTEM PIVOT TRIAL (SCENT) | Stryker Corporation | $491,895 | 0 |
| IIS: SAFETY AND EFFICACY ASSESSMENT OF SURPASS STREAMLINE FLOW DIVERTER IN THE US | Stryker Corporation | $167,911 | 0 |
| IN VITRO PERFORMANCE EVALUATIONS OF STRYKER NEUROVASCULAR DEVICES | Stryker Corporation | $24,217 | 0 |
| DEVELOPMENT OF THREE-DIMENSIONAL BONE DATABASE FOR SCAPU | Stryker Corporation | $17,023 | 0 |
| ATLAS | Stryker Corporation | $6,045 | 0 |
| THE CITADEL EMBOLIZATION DEVICE FEASIBILITY STUDY | Stryker Corporation | $3,638 | 0 |
Top Doctors Receiving Payments for SURPASS EVOLVE — Page 4
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , D.O | Neurological Surgery | Southfield, MI | $5,098 | 5 |
| , M.D | Neurological Surgery | Houston, TX | $4,859 | 8 |
| , MD | Vascular Neurology | Cleveland, OH | $4,781 | 4 |
| , M.D., M.SC | Diagnostic Neuroimaging | San Francisco, CA | $4,713 | 24 |
| , MD, PHD | Neuroradiology | Stanford, CA | $4,702 | 13 |
| , M.D | Neurological Surgery | Tampa, FL | $3,801 | 8 |
| , PA-C | Surgical | Oro Valley, AZ | $3,655 | 153 |
| , MD | Sports Medicine | Boston, MA | $3,500 | 1 |
| , M.D., PH.D | Neurological Surgery | Buffalo, NY | $3,450 | 2 |
| , M.D | Foot and Ankle Surgery | Quakertown, PA | $3,325 | 1 |
| , MD | Neurological Surgery | Charlotte, NC | $3,299 | 7 |
| , MD | Neurological Surgery | Richmond, VA | $3,125 | 6 |
| , APRN | Nurse Practitioner | Tucson, AZ | $2,944 | 124 |
| , MBCHB | Vascular & Interventional Radiology | La Crosse, WI | $2,781 | 33 |
| , M.D | Neurology | Fort Pierce, FL | $2,735 | 8 |
| , M.D | Neuroradiology | San Francisco, CA | $2,676 | 9 |
| , MD | Neurological Surgery | Williamsville, NY | $2,568 | 2 |
| , MD | Neuroradiology | Philadelphia, PA | $2,477 | 20 |
| , MD | Neuroradiology | Miami Beach, FL | $2,418 | 29 |
| , M.D | Student in an Organized Health Care Education/Training Program | San Francisco, CA | $2,336 | 5 |
| , MD | Neurocritical Care | Flint, MI | $2,304 | 16 |
| , M.D | Student in an Organized Health Care Education/Training Program | West Islip, NY | $2,000 | 1 |
| , MD | Vascular Neurology | Atlanta, GA | $1,995 | 11 |
| , MD | Diagnostic Radiology | San Francisco, CA | $1,945 | 7 |
| , MD | Neurological Surgery | Fort Worth, TX | $1,929 | 4 |
Ad
Manufacturing Companies
- Stryker Corporation $8.0M
Product Information
- Type Device
- Total Payments $8.0M
- Total Doctors 1,071
- Transactions 7,889
About SURPASS EVOLVE
SURPASS EVOLVE is a device associated with $8.0M in payments to 1,071 healthcare providers, recorded across 7,889 transactions in the CMS Open Payments database. The primary manufacturer is Stryker Corporation.
Payment data is available from 2021 to 2024. In 2024, $1.8M was paid across 1,854 transactions to 428 doctors.
The most common payment nature for SURPASS EVOLVE is "Consulting Fee" ($4.0M, 50.2% of total).
SURPASS EVOLVE is associated with 7 research studies, including "EVOLVE" ($2.5M).